FindTrial
Sign In

Effect of the drug on small intestine injuries

Effect of the drug on small intestine injuries retrospectively assessed by capsule endoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004795
Enrollment
400
Registered
2020-03-05
Start date
2020-03-31
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hallym University Medical Center-Dongtan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 20-90 years old 2. persons who received capsule endoscopy for small bowel evaluation from January 2014 to November 2019 at our Hospital

Exclusion criteria

Exclusion criteria: 1. a final diagnosis of intentinal Tuberculosis, inflammatory bowel disease (IBD), Behcet's disease, or Henoch–Schönlein purpura (HS purpura), small bowel lymphoma 2. Ages less than 20 years and over 90 years 3. Patients who lost follow-up prior to final diagnosis 4. Incomplete study (capsules did not enter the large intestine until the test is over, bowel preparation was poor, or the vision was very bad with a lot of bleeding)

Design outcomes

Primary

MeasureTime frame
risk factors (mainly medications) for the small intestinal injuries—

Secondary

MeasureTime frame
association between reason for the test and small bowel injuries—

Countries

Korea, Republic of

Contacts

Public ContactSang Pyo Lee

Hallym University Medical Center-Dongtan

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 26, 2026